DISPOSITION OF INTRAVENOUS PIRMENOL

被引：15

作者：

SANDERS, SW

NAPPI, JM

FOLTZ, RL

LUTZ, JR

ANDERSON, JL

机构：

[1] UNIV UTAH,COLL PHARM,CTR HUMAN TOXICOL,SALT LAKE CITY,UT 84112

[2] UNIV UTAH,COLL MED,SALT LAKE CITY,UT 84112

[3] LATTER DAY ST HOSP,SALT LAKE CITY,UT 84143

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 23卷 / 2-3期

关键词：

D O I：

10.1002/j.1552-4604.1983.tb02713.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：113 / 122

页数：10

共 11 条

[1]

GIBALDI M, 1975, PHARMACOKINETICS, P731

[2] PIRMENOL, A NEW ANTIARRHYTHMIC AGENT - INITIAL STUDY OF EFFICACY, SAFETY AND PHARMACOKINETICS [J].

HAMMILL, SC ;

SHANDDG ;

ROUTLEDGE, PA ;

HINDMAN, MC ;

BAKER, JT ;

PRITCHETT, ELC .

CIRCULATION, 1982, 65 (02) :369-375

[3]

MERTZ T, 1978, PHARMACOLOGIST, V20, P149

[4]

METZLER CM, 1974, BIOMETRICS, V30, P562

[5] PHARMACOKINETIC ANALYSIS BY LINEAR-SYSTEM APPROACH .1. CIMETIDINE BIOAVAILABILITY AND SECOND PEAK PHENOMENON [J].

PEDERSEN, PV .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (01) :32-38

[6] EFFECTS OF PIRMENOL HCL ON ELECTROPHYSIOLOGIC PROPERTIES OF CARDIAC PURKINJE-FIBERS [J].

REDER, RF ;

DANILO, P ;

ROSEN, MR .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 61 (04) :321-333

[7] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF A NEW ANTI-ARRHYTHMIC DRUG, PIRMENOL, IN BIOLOGICAL-FLUIDS [J].

SHAND, DG ;

VERGHESE, C ;

BARCHOWSKY, A ;

HAMMILL, SC ;

PRITCHETT, ELC .

JOURNAL OF CHROMATOGRAPHY, 1981, 224 (02) :343-347

[8]

SHAND DG, 1980, CLIN PHARMACOL THER, V29, P542

[9] EVALUATION OF METHODS FOR ESTIMATING POPULATION PHARMACOKINETIC PARAMETERS .2. BIEXPONENTIAL MODEL AND EXPERIMENTAL PHARMACOKINETIC DATA [J].

SHEINER, LB ;

BEAL, SL .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (05) :635-651

[10]

STEFFE TJ, 1980, J PHARMACOL EXP THER, V214, P40

← 1 2 →